MORGAN ARTIS: Open Payments
NPI 1487306858 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,812 in 72 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $495 · 2025 $1,812
Food & beverage: $1,812
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $329 |
| Corcept Therapeutics | 7 | $311 |
| AstraZeneca Pharmaceuticals LP | 4 | $196 |
| Exact Sciences Corporation | 6 | $183 |
| Novo Nordisk Inc | 7 | $156 |
| Lilly USA, LLC | 4 | $136 |
| Antares Pharma, Inc. | 5 | $85 |
| Illumina, Inc. | 1 | $80 |
| Noven Therapeutics, LLC | 3 | $61 |
| Astellas Pharma US Inc | 3 | $51 |
Products named: Korlym, VRAYLAR, Cologuard Collection Kit, AIRSUPRA, MOUNJARO, XYOSTED, UBRELVY, Oncology Testing.
Industry payments across TX — which companies pay providers there.
